Listen "Impact of COVID-19 to the Biotech and Diagnostics Industry"
Episode Synopsis
The biotech and diagnostics industry have evolved significantly in the past few months with the impact of COVID. To get a better perspective of the state of this sector, I spoke with our biotech experts Caroline Popper, M.D. in the US and Bob Atwill in Australia.
More episodes of the podcast M&A Perspectives
The Oil & Gas Sector Rebounds In 2021
06/04/2021
2021 Outlook: Private Capital Market
29/01/2021
What is driving the US M&A Market?
01/12/2020
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.